End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
2014 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Tech/Sci/R&D Officer | 69 | 02-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 11-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,969,163 | 107,500,142 ( 99.57 %) | 0 | 99.57 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- Stock
- Company InterMune Inc